Amerisource Health Services LLC is recalling 61,231 bottles of Potassium Chloride Extended-Release Capsules, USP (750 mg, 10 mEq K) sold under the BluePoint Laboratories brand. The medication was found to fail dissolution specifications, meaning the capsules may not break down and release the active ingredient as intended. The recall affects several lots of 100-count and 500-count bottles with expiration dates ranging from July 2024 to September 2025.
If the medication fails to dissolve properly, patients may receive an incorrect dose of potassium, potentially leading to poorly managed potassium levels. This can cause serious health complications if blood potassium levels are not maintained within the target range.
You have 2 options:
Manufactured by Glenmark Pharmaceuticals Ltd.; Distributed for BluePoint Laboratories.
Manufactured by Glenmark Pharmaceuticals Ltd.; Distributed for BluePoint Laboratories.
Label, Glenmark Potassium Chloride Extended Release 750mg Capsules, 100 count
Label, Glenmark Potassium Chloride Extended Release 750mg Capsules, 500 count
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.